CX-8998 (T-Wave)
PRECLINICAL
PHASE 1
PHASE 2
PHASE 3
PRE
P1
P2
P3
Pipeline Type
New Drugs in Development
Phase Of Development
Phase 2
Sponsors and Collaborators
Cavion
Mechanism of Action
Ion Channel
Mechanism Description
Modulate T-type calcium channels
Populations Tested In
Absence Seizures
Other Resources
Special FDA Designation
Nonprofit or Government Support
N/A
Nonprofit or Government Support Description
N/A
Previous Presentations
Presented at meetings (latest date) (Pipeline, AEDD; AES, Eilat, etc)
Pipeline 2018
Location of Clinical Trials
N/A
Clinical Trial link